Challenges in Diagnosing and Reporting Cholangiocarcinoma.
Bile duct hamartoma
Biliary duct adenoma
Cholangiocarcinoma
Intrahepatic
Large duct type iCCA
Small duct type iCCA
cHCC-CCA
iCCA
Journal
Surgical pathology clinics
ISSN: 1875-9157
Titre abrégé: Surg Pathol Clin
Pays: United States
ID NLM: 101491209
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
medline:
7
8
2023
pubmed:
4
8
2023
entrez:
3
8
2023
Statut:
ppublish
Résumé
Intrahepatic cholangiocarcinoma is a challenge to the practicing surgical pathologist for several reasons. It is rare in many parts of the world, and thus practical exposure may be limited. Related to the fact of its rarity is the fact that more common tumors which frequently metastasize to the liver can be morphologically indistinguishable (eg, pancreatic ductal adenocarcinoma). Immunohistochemical testing is generally non-contributory in this context. Other difficulties arise from the protean morphologic manifestations of cholangiocarcinoma (ie, small duct vs. large duct) and the existence of combined cholangiocarcinoma and hepatocellular carcinoma. These, and other issues of concern to the practicing diagnostic pathologist are discussed herein.
Identifiants
pubmed: 37536891
pii: S1875-9181(23)00038-7
doi: 10.1016/j.path.2023.04.012
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
599-608Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.